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Abstract
Introduction: The detection of adenomas is the basic goal for colorectal cancer screening programs; therefore, every possi-
bility to improve the adenoma detection rate is valuable. 
Aim: To answer the question of whether narrow-band imaging (NBI) can enhance detection quality in screening for colo-
noscopy. 
Material and methods: A group of 533 patients (202 men: 331 women; average age: 56.1 years) included in a colorectal can-
cer screening program were randomised into two groups (NBI n = 266 and white light (WL) n = 267). Five hundred and twenty- 
seven patients were finally included in the assessment. Examinations were performed by three experienced colonoscopists. The 
NBI was used only at the withdrawal of the instrument.
Results: Comparing WL and NBI colonoscopies, differences in the mean number of detected polyps per patient (1.36 ±2.79 
WL vs. 1.65 ±2.11 NBI; p = 0.012), polyp detection rate (PDR) (48.5% WL vs. 57.2% NBI; p = 0.049), PDR for polyps ≤ 5 mm (44.7% 
WL vs. 54% NBI; p = 0.033), and PDR for left-sided polyps (43.3% WL vs. 52.7% NBI; p = 0.033) were observed. The difference in 
adenoma detection rate (ADR) as well as in adenomas/patient was not significant. Narrow-band imaging enhanced significantly 
one of three operators’ ADR (15.6% WL vs. 25.7% NBI; p = 0.038). 
Conclusions: It seems that NBI improves only detection of hyperplastic polyps, especially those that are diminutive and 
left-sided. However, after analysis of particular endoscopists, it can clearly be seen that some of them may benefit from NBI.
Introduction 
Colorectal cancer (CRC) is still one of the most 
common causes of cancer and cancer-related death 
worldwide [1]. Therefore, it is still necessary to im-
prove prevention, screening, and treatment processes. 
Screening colonoscopy with polypectomy gives a great 
possibility to avoid CRC by removing adenomas that 
are pre-cancerous lesions [2]. Despite the fact that the 
adenoma detection rate (ADR) is a well-known tool for 
quality measurement of colonoscopy [3], it may vary, 
depending on the colonoscopist, from 7.4% to 52.5% 
[4]. The fact that, as mentioned above, there is a 22% 
polyp miss rate and 26% 1–5 mm adenoma miss rate 
[5] demands a constant search for improvement in 
polyp and adenoma detection. For that reason, multi-
ple devices were invented to help enhance adenoma 
detection [6]. Narrow-band imaging is a visual sys-
tem provided by an optical filter 415 nm for blue and 
540 nm for green light, which enhances visibility of 
mucosal vessels due to absorption of haemoglobin. 
Despite a number of trials in this field [7–17], a lack of 
data is observed, especially in the homogenous pop-
ulation for screening colonoscopy performed in the 
same conditions, which can answer the question of 
whether narrow-band imaging (NBI) can improve the 
quality of detection in comparison to classic colonos-
copy examination. 
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Aim
The aim of the study was to verify if NBI can help 
experienced endoscopists to improve their detection 
indicators. 
Material and methods
Study design and patients
This was a prospective, randomised study con-
ducted from 22/JUN/2007 until 4/DEC/2007, approved 
by the Silesian Ethics Commission, conducted in ac-
cordance with the Declaration of Helsinki. Written, 
informed consent was obtained from all patients. Pa-
tients were recruited from the national colorectal can-
cer screening programme. The programme inclusion 
criteria were: age 50–65 or 40–65 years if CRC occurred 
in a first-degree relative, without any symptoms such 
as gastrointestinal bleeding, diarrhoea or constipation 
during last months with unknown cause, body mass 
loss, anaemia with unknown cause, and without colo-
noscopy performed in the last 10 years. Patients with 
inflammatory bowel disease were not included in the 
screening programme. The sample size was estimated 
assuming that the increase of ADR from approx. 18%, 
which was known in our centre, to 30% requires at least 
198 patients for each group with 80% statistical power 
and a significance level of 0.05 (two-sided). The prima-
ry outcome measure was the adenoma detection rate 
(ADR). The secondary outcome  measure included: num-
ber of adenomas, mean number of adenomas per pa-
tient, ADR for left and right-sided adenomas, polyp de-
tection rate (PDR), number of polyps, mean number of 
polyps per patient, PDR for right and left-sided polyps, 
number of polyps < 5 mm, and PDR for polyps < 5 mm. 
A group of 533 individuals (202 men, 331 women; av-
erage age: 56.1 years) included in the colorectal can-
cer screening programme was randomised into two 
groups in a 1 : 1 ratio by using a randomisation list (NBI 
n = 266 and white light (WL) n = 267).
Colonoscopy
Individuals were prepared with four litres of polyeth-
ylene glycol solution in split doses. If the examination 
was performed before 12 a.m., half of the solution was 
taken the day before the examination. Patients were 
sedated or consciously premedicated with midazolam 
1 mg and fentanyl 50 µg depending on the individu-
al’s preference. All examinations were performed at 
H-T Centrum Medyczne-Endoterapia Tychy, Poland by 
three experienced colonoscopists (> 10,000 colonoscopies 
performed by each), who were familiar with NBI imaging. 
Bowel preparation was described as good, fair, or poor. Pa-
tients with good or fair bowel preparation were included 
in the assessment. Colonoscopies were performed using 
EVIS EXERA II system colonoscopes (Q180AI). 
Every examination was performed in WL during 
insertion, after reaching the caecum, patients were 
randomised into the WL or NBI group in a 1 : 1 ratio. 
The withdrawal time was neither measured nor esti-
mated; however, in the colonoscopy protocol the time 
of withdrawal was at least 6 min. In patients who were 
randomised to the NBI group, NBI was used during the 
whole drawing out procedure, apart from polypecto-
mies, which were performed in WL. After polypectomy 
the examination was continued with NBI. Polyps were 
measured by opened forceps or a snare and removed 
by using a snare, hot biopsy, biopsy forceps, and mu-
cosectomy. The location of polyps was described as 
“left-sided” if distal to splenic flexure or “right-sided” 
if proximal to splenic flexure. Patients who had polyps 
larger than 10 mm or needed preparation for polypec-
tomy were not excluded from the assessment; howev-
er, only the polyps  described in screening colonoscopy 
were included in the assessment after  polypectomy 
and histopathological examination.
Statistical analysis
The data are presented as means with correspond-
ing standard deviations (SD) or medians with the quar-
tiles (Q1,Q3) depending on whether normal distribution 
was present. The Shapiro-Wilk test was used to deter-
mine if the quantitative data was normally distributed. 
To verify the homogeneity of variance, Levene’s test 
was performed. We also used Student’s t-tests and 
the Mann-Whitney U test for statistical comparisons 
between two groups. Kruskal-Wallis one-way analysis 
of variance with Bonferroni correction was performed 
to determine significant differences between operators. 
Statistical comparisons for categorical data were per-
formed using the c2 or Fisher exact tests. In this case 
the Bonferroni correction was applied to resolve the 
problem of multiple testing and of finding at least one 
significant result just due to chance. The significance 
level was set to be less than 0.0167; Graphs were gen-
erated to present the proportion of patients with polyps 
and adenoma rates per consecutive group, where one 
group was composed of 50 study participants. We per-
formed statistical analyses with Statistica v12 (StatSoft 
Inc., Tulsa, OK, USA). A p-value of less than 0.05 was 
considered to be statistically significant.
Results
Research in general
A group of 533 patients (202 men and 331 wom-
en; average age: 56.15 years) included in the colorec-
tal cancer screening programme were randomised into 
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two groups (NBI n = 266 and WL n = 267). Five hundred 
and twenty-seven patients were finally included in the 
assessment; 6 patients were excluded (three NBI, three 
WL; 5 females, 1 male) due to inadequate bowel prepa-
ration (Figure 1). Caecum was reached in all colonosco-
pies; only one cancer occurred in hepatic flexure – we 
did not exclude this patient from assessment because 
caecum was reached. Differences in sex, age, and se-
dation rate were not significant (Table I). In the whole 
study 792 polyps were detected – 358 in the WL group 
and 434 in the NBI group; differences in PDR (48.5% 
vs. 57.2% NBI; p = 0.049) and a mean number of pol-
yps per patient (1.36 ±2.79 WL vs. 1.65 ±2.11 NBI; p = 
0.012) were significant. Seven hundred and twenty-four 
of 792 (91.4%) were diminutive polyps (< 5 mm); 318 
WL, 406 NBI. Narrow-band imaging enhanced significant-
ly diminutive polyp detection (44.7% WL vs. 54.0% NBI, 
p = 0.033). Six hundred and ninety polyps were locat-
ed on the left side of the colon distal to splenic flexure 
(303 WL vs. 387 NBI), and 102 were located on the right 
side (55 WL vs. 47 NBI). The detection rate for left-sided 
polyps was significantly higher in the NBI group (44.3% 
WL vs. 52.7% NBI, p = 0.033) unlike right-sided polyps – 
the difference was not statistically significant (12.9% WL 
vs. 12.5% NBI). One hundred and eighty adenomas were 
detected – 81 in the WL group and 99 in the NBI group. 
Adenoma detection rate (ADR) in the whole research 
was 21.25%. There was no significant difference in ADR 
(19.31% WL vs. 23.19% NBI) nor in the mean number 
of adenomas per patient (0.3 ±0.80 WL vs. 0.37 ±0.81 
NBI). NBI enhanced detection of adenomas on the left 
side of the colon (57 WL vs. 68 NBI) and on the right side 
(25 WL vs. 30 NBI); however, the differences in detection 
rates were not statistically significant. Eleven adenomas 
with high-grade dysplasia were found (8 WL vs. 3 NBI); 
the difference in detection rates was not significant. Only 
one cancer was found, in the NBI group. The statistics are 
shown in Table I.
Learning effect 
The differences between the first 100 and last 100 
colonoscopies performed (Table II) in PDR and ADR 
were not significant; however, a slight improvement of 
ADR in the NBI group was observed (21.0% vs. 23.0%). 
Graphic presentation of ADR and PDR during the stud-
ies is shown in Figures 2 and 3.
Operator comparison
A comparison of the operators is presented in Table III.
Discussion
Narrow-band imaging has been used successfully 
in endoscopy and in several studies [7–17] as well as 
meta-analyses [16, 18–20] that were conducted to de-
termine whether this imaging technique improves the 
quality of colonoscopy. Data seem to be explicit about 
the influence of NBI on adenoma detection rates: it is 
not superior to standard imaging [7–11, 13, 15–20]. Our 
study also showed that the use of narrow-band imag-
ing did not improve ADR in general. It only improved 
the detection of hyperplastic polyps, and it seems to 
be comparable to studies with a large number of pa-
tients included, conducted at that time – ADR obtained 
at 21% [7]. On the other hand, a recent tandem trial 
showed that ADR was significantly higher in HD-NBI vs. 
HD imaging [12]. 
Narrow-band imaging improved the number of de-
tected adenomas located on the left side as well as on 
the right side of the colon; however, the differences 
were not significant. Higher right-sided adenoma detec-
tion would be desired to avoid right-sided CRC, which 
occurs more frequently after colonoscopy than in the 
general population [21]. 
Similarly to another study [17], we also did not ob-
serve any significant learning effect. The comparison of 
the first and last 100 examinations did not show any 
significant ADR improvement (as well as PDR). However, 
the ADR of the last 100 examinations was higher than 
first 100 colonoscopies (23% vs. 21%). On the graphic 
presentation it is clear that a slightly growing trend is 
present in the NBI group. This suggests that some detec-
tion enhancement might exist when using NBI. Colonos-
copies were performed by experienced colonoscopists 
(over 10,000 colonoscopies each) in one site, and the 
main colonoscopy quality indicator, the adenoma detec-
tion rate, did not vary among operators. Nevertheless, 
when more precise analyses were performed the dif-
ferences among operators in ADR, PDR, polyps/patient, 
adenomas/patient in the white light imaging group oc-
curred (Table III). On the other hand, this analysis may 
be affected by the fact that operator 3 had performed 
533 Randomized
267 WL
264 performed 
in WL
266 NBI
263 performed 
in NBI
Inadequate bowel 
preparation (n = 3)
Inadequate bowel 
preparation (n = 3)
Figure 1. Subject enrolment
WL – White light, NBI – narrow-band imaging.
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Table I. Comparison between white light (WL) and narrow-band imaging (NBI) groups
Parameter WL (n = 264) NBI (n = 263) Total (n = 527) P-value
Male 90 111 201 0.55
Female 174 152 326
Average age [years] 55.8 ±5.0 56.5 ±4.4 56.1 ±4.7 0.28
Sedation, n (%) 23 (8.7) 14 (5.3) 37 (7.0) 0.13
Polyps:
All polyps 358 434 792
PDR 48.5% 57.2% 55.0% 0.049
Polyps/patient (SD) 1.36 (2.79) 1.65 (2.11) 1.5 (2.48) 0.012
Polyps < 5 mm 318 406 724
PDR < 5 mm 44.7% 54% 49.3% 0.033
Left-sided 303 387 690
PDR left-sided 43.3% 52.7% 48% 0.033
Right-sided 55 47 102
PDR right-sided 12.9% 12.5% 12.7% 0.89
Adenomas:
All adenomas 81 99 180
ADR 19.31% 23.19% 21.25% 0.27
Adenomas/patient (SD) 0.30 (0.81) 0.37 (0.81) 0.34 (0.81) 0.42
Left-sided 57 68 125
ADR left-sided 14.4% 17.4% 15.9% 0.35
Right-sided 25 30 55
ADR right-sided 6.5% 8% 7.2% 0.51
HGD adenomas 8 3 11
ADR HGDA 1.89% 0.76% 1.3% 0.26
Cancer 0 1 1 –
Operator 1:
PDR 46.0% 57.4% 0.07
ADR 15.6% 25.7% 0.038
Polyps/patient (SD) 1.1 (2.08) 1.54 (1.82) 0.015
Adenomas/patient (SD) 0.19 (0.49) 0.43 (0.89) 0.11
Operator 2:
PDR 63.5% 58.3% 0.56
ADR 30.6% 19.4% 0.09
Polyps/patient (SD) 2.25 (3.94) 1.95 (2.51) 0.74
Adenomas/patient (SD) 0.6 (1.22) 0.31 (0.74) 0.14
Operator 3:
PDR 23.7% 47.4% 0.13
ADR 7.9% 26.3% 0.14
Polyps/patient (SD) 0.32 (0.62) 0.74 (0.99) 0.14
Adenomas/patient (SD) 0.08 (0.27) 0.32 (0.58) 0.25
Polyps detection rate (PDR) – patients with at least one polyp, adenoma detection rate (ADR) – patients with at least one adenoma, SD – standard deviation, 
HGD – high-grade dysplasia, HGDA – high-grade dysplasia adenomas, polyps/patient – mean number of polyps per patient, adenomas/patient – mean 
number of adenomas per patient.
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a small number of colonoscopies in that study. Despite 
non-significant results, ADR can vary from 14% to 24.3% 
even when colonoscopies were performed in compara-
ble conditions and with similar equipment by experi-
enced specialists. Data from the Polish CRC screening 
programme showed a median ADR of 12.2% [3]; how-
ever, a recent population-based randomised clinical trial 
showed a mean ADR of 30.6% (newer equipment may 
affect that figure) [22]. Interesting results show analysis 
of every operator. Operator 1, who had performed the 
largest number of colonoscopies in this study, benefited 
from using NBI, and, surprisingly, the differences were 
significant. Operator 2 in this study had the highest ADR 
(24.3%), and despite non-significant differences, NBI de-
creased the ADR by 11.2% (30.6% WL vs. 19.4% NBI). 
In addition, he had better PDR polyps/patient and ade-
nomas/patient ratings at standard imagination. Opera-
tor 3 also benefited from NBI (ADR 7.9% WL vs. 26.3% 
NBI); however, the number of colonoscopies performed 
in this study (57) may affect this. This analysis suggests 
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Figure 3. Changes of proportion of patients with 
adenomas during study 
that examinations performed in WL are enough to reach 
a high adenoma detection rate. On the other hand, in 
white light imaging differences in ADR among operators 
were significant, and in the NBI group two of the three 
operators improved the ADR. Therefore, differences in 
ADR were not significant. A similar outcome was shown 
in another study; however, it was conducted on patients 
with high risk of adenomas, not in a general screening 
population [10]. 
This makes it possible to suggest that expertise in 
NBI might upgrade the quality of colonoscopy and im-
prove the quality of lesion detection in centres with dif-
ferences in ADR between operators. These statements 
create the hypothesis that the personalisation of colo-
noscopy technique by using NBI is not a firm recom-
mendation or guideline but may have the desired result 
in upgrading the quality of colonoscopy. Such a case 
pertains particularly to experienced endoscopists who 
have not reached the desired ADR level, and it should 
not be used for trainees.
This study has several limitations: firstly, colonosco-
pies were performed in 2007 using the EXCERA II system 
on non-HD endoscopes. Meta-analysis shows differences 
in ADR of 3.5% between WL and WL-HD [23], and now 
the European Society of Gastrointestinal Endoscopy 
(ESGE) recommend use of high-definition endoscopes 
[24]. Secondly, the EXCERA II NBI system is known to be 
darker than the current EXCERA III, which may lead to 
indirect translation between previous and current NBI sys-
tems. Also, the study was conducted by three experienced 
endoscopists, so the results are related to clinicians who 
have performed a vast number of colonoscopies. 
Conclusions
Our results regarding routine use of NBI by experi-
enced operators during screening colonoscopy show no 
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Table II. Comparison of first 100 and last 100 colo-
noscopies performed in white light (WL) and narrow-
band imaging (NBI)
Variable First 100 Last 100 P-value
PDR:
WL 49.0% 46.0% 0.67
NBI 60.0% 53.0% 0.32
ADR:
WL 19.0% 19.0% 1
NBI 21.0% 23.0% 0.73
Polyp detection rate (PDR) – patients with at least one polyp, adenoma 
detection rate (ADR) – patients with at least one adenoma.
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benefit of NBI use. However, some operators may bene-
fit from using this imaging technique, and it should be 
considered individually according to the preference and 
outcome from colonoscopies performed.
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